Biologics litigation, the first cases under the new PMNOC Regulations, the first Certificates of Supplementary Protection issued (and the first rejection!), patent prosecution developments and Galderma headed to the FCA : 2018 has been an exciting year in Canadian pharmaceutical law so far. Join IPIC’s Life Science Subcommittee for all the latest and greatest on these topics and more.

Melanie Szweras
Bereskin & Parr LLP

Andrew Skodyn
Blake, Cassels & Graydon LLP

Mee Ling Wong
Wilson Lue LLP

Emily Kettel
Bennett Jones LLP